Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP645131.RAngj3FCiSdp-RxeR9IZbHG8omMsM1n6ggRMmONyc1lfo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645131.RAngj3FCiSdp-RxeR9IZbHG8omMsM1n6ggRMmONyc1lfo130_assertion type Assertion NP645131.RAngj3FCiSdp-RxeR9IZbHG8omMsM1n6ggRMmONyc1lfo130_head.
- NP645131.RAngj3FCiSdp-RxeR9IZbHG8omMsM1n6ggRMmONyc1lfo130_assertion description "[In conclusion, we show that PIM2 kinase inhibition is a rational approach in DLBCL treatment, identify appropriate biomarkers for pharmacodynamic studies, and provide a new marker for patient stratification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645131.RAngj3FCiSdp-RxeR9IZbHG8omMsM1n6ggRMmONyc1lfo130_provenance.
- NP645131.RAngj3FCiSdp-RxeR9IZbHG8omMsM1n6ggRMmONyc1lfo130_assertion evidence source_evidence_literature NP645131.RAngj3FCiSdp-RxeR9IZbHG8omMsM1n6ggRMmONyc1lfo130_provenance.
- NP645131.RAngj3FCiSdp-RxeR9IZbHG8omMsM1n6ggRMmONyc1lfo130_assertion SIO_000772 21937691 NP645131.RAngj3FCiSdp-RxeR9IZbHG8omMsM1n6ggRMmONyc1lfo130_provenance.
- NP645131.RAngj3FCiSdp-RxeR9IZbHG8omMsM1n6ggRMmONyc1lfo130_assertion wasDerivedFrom befree-20140225 NP645131.RAngj3FCiSdp-RxeR9IZbHG8omMsM1n6ggRMmONyc1lfo130_provenance.
- NP645131.RAngj3FCiSdp-RxeR9IZbHG8omMsM1n6ggRMmONyc1lfo130_assertion wasGeneratedBy ECO_0000203 NP645131.RAngj3FCiSdp-RxeR9IZbHG8omMsM1n6ggRMmONyc1lfo130_provenance.